A detailed history of Truist Financial Corp transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Truist Financial Corp holds 20,911 shares of DGX stock, worth $2.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,911
Previous 19,294 8.38%
Holding current value
$2.87 Million
Previous $2.64 Million 8.56%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$137.09 - $137.09 $221,674 - $221,674
1,617 Added 8.38%
20,911 $2.87 Million
Q2 2024

Aug 20, 2024

SELL
$125.91 - $144.34 $172,748 - $198,034
-1,372 Reduced 6.64%
19,294 $2.64 Million
Q1 2024

May 10, 2024

BUY
$123.78 - $142.11 $545,498 - $626,278
4,407 Added 27.1%
20,666 $2.75 Million
Q4 2023

Feb 02, 2024

BUY
$120.62 - $141.12 $318,436 - $372,556
2,640 Added 19.38%
16,259 $2.24 Million
Q3 2023

Nov 14, 2023

SELL
$121.86 - $144.92 $543,130 - $645,908
-4,457 Reduced 24.66%
13,619 $1.66 Million
Q2 2023

Aug 01, 2023

SELL
$130.56 - $146.84 $702,804 - $790,439
-5,383 Reduced 22.95%
18,076 $2.54 Million
Q1 2023

May 05, 2023

BUY
$131.53 - $155.76 $64,975 - $76,945
494 Added 2.15%
23,459 $3.32 Million
Q4 2022

Feb 17, 2023

BUY
$123.31 - $157.26 $512,599 - $653,729
4,157 Added 22.1%
22,965 $3.59 Million
Q3 2022

Oct 26, 2022

SELL
$121.77 - $141.1 $116,290 - $134,750
-955 Reduced 4.83%
18,808 $2.31 Million
Q2 2022

Jul 22, 2022

SELL
$127.07 - $145.39 $308,271 - $352,716
-2,426 Reduced 10.93%
19,763 $2.63 Million
Q1 2022

Apr 22, 2022

BUY
$129.09 - $164.35 $22,978 - $29,254
178 Added 0.81%
22,189 $3.04 Million
Q4 2021

Feb 14, 2022

BUY
$140.36 - $173.01 $1.07 Million - $1.32 Million
7,624 Added 52.99%
22,011 $3.81 Million
Q3 2021

Nov 05, 2021

BUY
$132.95 - $158.0 $250,078 - $297,198
1,881 Added 15.04%
14,387 $2.09 Million
Q2 2021

Aug 16, 2021

SELL
$126.66 - $141.48 $1.09 Million - $1.22 Million
-8,615 Reduced 40.79%
12,506 $1.65 Million
Q1 2021

May 17, 2021

SELL
$114.63 - $133.34 $7.5 Million - $8.72 Million
-65,398 Reduced 75.59%
21,121 $2.71 Million
Q4 2020

Feb 18, 2021

BUY
$112.7 - $128.05 $7.48 Million - $8.5 Million
66,361 Added 329.2%
86,519 $10.3 Million
Q3 2020

Nov 05, 2021

SELL
$107.05 - $130.01 $4.96 Million - $6.02 Million
-46,336 Reduced 69.68%
20,158 $2.31 Million
Q3 2020

Nov 13, 2020

BUY
$107.05 - $130.01 $7.11 Million - $8.64 Million
66,430 Added 103796.88%
66,494 $7.61 Million
Q2 2020

Nov 16, 2021

SELL
$73.34 - $122.61 $5.98 Million - $10 Million
-81,553 Reduced 99.92%
64 $7,000
Q2 2020

Aug 14, 2020

BUY
$73.34 - $122.61 $2.43 Million - $4.06 Million
33,079 Added 68.15%
81,617 $9.3 Million
Q1 2020

Nov 05, 2021

BUY
$75.14 - $115.68 $4,808 - $7,403
64 Added 0.13%
48,538 $3.9 Million
Q1 2020

May 15, 2020

BUY
$75.14 - $115.68 $2.37 Million - $3.66 Million
31,597 Added 187.22%
48,474 $3.89 Million
Q4 2019

Nov 16, 2021

BUY
$100.29 - $107.99 $6,418 - $6,911
64 Added 0.38%
16,877 $1.8 Million
Q4 2019

Feb 14, 2020

BUY
$100.29 - $107.99 $1.69 Million - $1.82 Million
16,813 New
16,813 $1.8 Million
Q4 2018

Jan 22, 2019

SELL
$79.75 - $108.38 $200,970 - $273,117
-2,520 Closed
0 $0
Q3 2018

Oct 17, 2018

SELL
$105.42 - $114.99 $32,469 - $35,416
-308 Reduced 10.89%
2,520 $272,000
Q2 2018

Jul 26, 2018

SELL
$97.35 - $113.14 $116,041 - $134,862
-1,192 Reduced 29.65%
2,828 $311,000
Q1 2018

Apr 20, 2018

SELL
$96.42 - $107.88 $397,346 - $444,573
-4,121 Reduced 50.62%
4,020 $403,000
Q4 2017

Jan 29, 2018

SELL
$90.86 - $100.24 $148,737 - $164,092
-1,637 Reduced 16.74%
8,141 $802,000
Q3 2017

Oct 23, 2017

BUY
$91.96 - $108.35 $899,184 - $1.06 Million
9,778
9,778 $916,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.